Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.

Cissé M, Halabisky B, Harris J, Devidze N, Dubal DB, Sun B, Orr A, Lotz G, Kim DH, Hamto P, Ho K, Yu GQ, Mucke L.

Nature. 2011 Jan 6;469(7328):47-52. doi: 10.1038/nature09635. Epub 2010 Nov 28.

2.

Alzheimer's disease: Recollection of lost memories.

Malenka RC, Malinow R.

Nature. 2011 Jan 6;469(7328):44-5. doi: 10.1038/469044a. No abstract available.

3.

Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease.

Simón AM, de Maturana RL, Ricobaraza A, Escribano L, Schiapparelli L, Cuadrado-Tejedor M, Pérez-Mediavilla A, Avila J, Del Río J, Frechilla D.

J Alzheimers Dis. 2009;17(4):773-86. doi: 10.3233/JAD-2009-1096.

PMID:
19542617
4.

Protective effects of EphB2 on Aβ1-42 oligomer-induced neurotoxicity and synaptic NMDA receptor signaling in hippocampal neurons.

Geng D, Kang L, Su Y, Jia J, Ma J, Li S, Du J, Cui H.

Neurochem Int. 2013 Oct;63(4):283-90. doi: 10.1016/j.neuint.2013.06.016. Epub 2013 Jul 2.

PMID:
23831214
5.

The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function.

Henderson JT, Georgiou J, Jia Z, Robertson J, Elowe S, Roder JC, Pawson T.

Neuron. 2001 Dec 20;32(6):1041-56.

6.

Peptide EphB2/CTF2 generated by the gamma-secretase processing of EphB2 receptor promotes tyrosine phosphorylation and cell surface localization of N-methyl-D-aspartate receptors.

Xu J, Litterst C, Georgakopoulos A, Zaganas I, Robakis NK.

J Biol Chem. 2009 Oct 2;284(40):27220-8. doi: 10.1074/jbc.M109.048728. Epub 2009 Aug 6.

7.

Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function.

Ari C, Borysov SI, Wu J, Padmanabhan J, Potter H.

Neurobiol Aging. 2014 Aug;35(8):1839-49. doi: 10.1016/j.neurobiolaging.2014.02.006. Epub 2014 Feb 10.

8.

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.

Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM.

Nature. 2009 Feb 26;457(7233):1128-32. doi: 10.1038/nature07761.

9.

Reduction and the intracellular translocation of EphB2 in Tg2576 mice and the effects of β-amyloid.

Qu M, Jiang J, Liu XP, Tian Q, Chen LM, Yin G, Liu D, Wang JZ, Zhu LQ.

Neuropathol Appl Neurobiol. 2013 Oct;39(6):612-22. doi: 10.1111/nan.12019.

PMID:
23336960
10.

Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.

Izzo NJ, Staniszewski A, To L, Fa M, Teich AF, Saeed F, Wostein H, Walko T 3rd, Vaswani A, Wardius M, Syed Z, Ravenscroft J, Mozzoni K, Silky C, Rehak C, Yurko R, Finn P, Look G, Rishton G, Safferstein H, Miller M, Johanson C, Stopa E, Windisch M, Hutter-Paier B, Shamloo M, Arancio O, LeVine H 3rd, Catalano SM.

PLoS One. 2014 Nov 12;9(11):e111898. doi: 10.1371/journal.pone.0111898. eCollection 2014.

11.

Neural stem cell transplants improve cognitive function without altering amyloid pathology in an APP/PS1 double transgenic model of Alzheimer's disease.

Zhang W, Wang PJ, Sha HY, Ni J, Li MH, Gu GJ.

Mol Neurobiol. 2014 Oct;50(2):423-37. doi: 10.1007/s12035-014-8640-x. Epub 2014 Jan 31.

PMID:
24481678
12.

Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.

Zeng Y, Zhang J, Zhu Y, Zhang J, Shen H, Lu J, Pan X, Lin N, Dai X, Zhou M, Chen X.

J Neurochem. 2015 Apr;133(1):38-52. doi: 10.1111/jnc.13056. Epub 2015 Mar 8.

13.

Potassium 2-(1-hydroxypentyl)-benzoate promotes long-term potentiation in Aβ1-42-injected rats and APP/PS1 transgenic mice.

Li PP, Wang WP, Liu ZH, Xu SF, Lu WW, Wang L, Wang XL.

Acta Pharmacol Sin. 2014 Jul;35(7):869-78. doi: 10.1038/aps.2014.29. Epub 2014 May 26.

14.

Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L.

Neuron. 2007 Sep 6;55(5):697-711.

15.

Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.

Caccamo A, Branca C, Talboom JS, Shaw DM, Turner D, Ma L, Messina A, Huang Z, Wu J, Oddo S.

J Neurosci. 2015 Oct 14;35(41):14042-56. doi: 10.1523/JNEUROSCI.2781-15.2015.

16.

X11beta rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice.

Mitchell JC, Ariff BB, Yates DM, Lau KF, Perkinton MS, Rogelj B, Stephenson JD, Miller CC, McLoughlin DM.

Hum Mol Genet. 2009 Dec 1;18(23):4492-500. doi: 10.1093/hmg/ddp408. Epub 2009 Sep 10.

17.

FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders.

Kiyota T, Ingraham KL, Jacobsen MT, Xiong H, Ikezu T.

Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):E1339-48. doi: 10.1073/pnas.1102349108. Epub 2011 Oct 31. Erratum in: Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21282.

18.

Neuropsin cleaves EphB2 in the amygdala to control anxiety.

Attwood BK, Bourgognon JM, Patel S, Mucha M, Schiavon E, Skrzypiec AE, Young KW, Shiosaka S, Korostynski M, Piechota M, Przewlocki R, Pawlak R.

Nature. 2011 May 19;473(7347):372-5. doi: 10.1038/nature09938. Epub 2011 Apr 20.

19.
20.

Endogenous secreted amyloid precursor protein-alpha regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory.

Taylor CJ, Ireland DR, Ballagh I, Bourne K, Marechal NM, Turner PR, Bilkey DK, Tate WP, Abraham WC.

Neurobiol Dis. 2008 Aug;31(2):250-60. doi: 10.1016/j.nbd.2008.04.011. Epub 2008 May 10.

PMID:
18585048
Items per page

Supplemental Content

Write to the Help Desk